Tarsus Pharmaceuticals
@tarsusrx.com
Revolutionizing treatment for patients in need
Tarsus Pharmaceuticals's Company Logos
Tarsus Pharmaceuticals's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#52C6DA
Viking
82, 198, 218
189, 65, 59
62, 9, 0, 15
#FFDD65
Dandelion
255, 221, 101
47, 100, 70
0, 13, 60, 0
#00395B
Prussian Blue
0, 57, 91
202, 100, 18
100, 37, 0, 64
About Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a biopharmaceutical company that is revolutionizing treatment options for patients with limited options. Committed to therapeutic ingenuity, Tarsus brings novel therapies to a range of diseases. Their unique scientific approach focuses on diseases with high unmet needs like Demodex blepharitis, Lyme disease prevention, Meibomian Gland Disease, and Rosacea.
They have developed an FDA-approved treatment called XDEMVY™ (lotilaner ophthalmic solution) 0. 25% for patients living with Demodex blepharitis. Tarsus also has an impressive pipeline of innovative treatments in development, including TP-03, TP-04, and TP-05.
Investors can find additional corporate and stock information on their website, along with news releases, presentations, and upcoming events. Tarsus Pharmaceuticals is committed to delivering boundless therapeutic solutions and improving the lives of patients in need
Company type
Public Company
Year founded
2017
Company size
201-500 employees
Related Brands
Tags
FDA-approved ophthalmic treatment
Demodex blepharitis
Lotilaner ophthalmic solution
Ocular rosacea
Lyme disease prophylaxis
